Mike Hollan

This makes Aetna the first major insurer to cover these types of services.

The novel lipid-in-oil delivery platform showed positive results across multiple disease states.

The two companies will work together to accelerate the drug discovery process for cancer treatments.

Rizzo discusses Veeva’s latest findings on how life sciences companies are utilizing this strategy to speed up uptake of new treatments.

The updated formulas should provide better protection against the currently circulating strains.

Gilad discusses the ways that this method can be used to treat various cancers without putting patients through the side effects of chemotherapy.

This agreement will allow the diagnostic information services company to expand its operations in Ohio.

Kelly discusses how the company takes a different approach to spinal cord injuries.

The pharmaceutical company worked with Coursera to develop the three-module course.

The acquisition will allow Lilly to add Morphic’s IBF treatment to its pipeline.

Culjat discusses FDA’s new draft framework on PDURS.

The test is the first of its kind and is available over the counter.

Astellas Pharma’s chief people officer and chief ethics & compliance officer discusses the unique ways he’s brought DE&I to the workplace.

Key approval signals progress in addressing immune-mediated inflammatory diseases.

New cardiovascular indication builds on treatment’s fast-growing legacy.

The campaign, More to Parkinson’s, will focus on providing education about Parkinson’s related hallucinations.

Heidi Capozzi previously served as chief people officer for McDonald’s.

According to the company, about one-third of the country is at risk for micronutrient deficiency.

It’s time to see where artificial intelligence is genuinely being utilized in pharma.

Abrams discusses how both new pharma and big pharma are reacting to each other and the current market.

The company worked in partnership with Neurocode.

PicnicHealth’s CEO discusses how AI is making data more useful to the life sciences industry.

The Trinity Life Sciences managing director and head of DE&I strategy discusses recent research on the topic.

The two companies will combine assets to develop a device that make automatic adjustments.

Independence Blue Cross and Jefferson health published a study detailing the impact of such care.

The foundation donated over $1 million to these programs.

The life sciences technology company will be able to offer services to the pharmacies associated with Legacy.

Respondents said logistic reasons kept them from going to the doctor.

The company provided guidance for how people in the storm’s path can prepare ahead of time and ensure they have access to medication.

The team launched from California and rowed to one of the islands of Hawaii.